Last updated: February 20, 2026
What does patent NZ575133 cover?
Patent NZ575133 is a national patent granted by the Intellectual Property Office of New Zealand. It focuses on a specific pharmaceutical compound, formulation, or use, typically aligned with active ingredient claims or method-of-use protection.
Given the format and numbering, NZ575133 is likely a standard patent application for a new drug substance or medical use. Its scope can be summarized in terms of patent claims, which define rights boundary:
- Primary Claims: Usually specify the chemical compound or a pharmaceutical composition involving the active ingredient.
- Method Claims: Cover specific medical uses, preparation methods, or delivery systems.
- Dependent Claims: Narrower claims, adding specific features such as dosage forms, excipients, or particular administration modes.
Without access to the full patent document, the detailed claims typically encompass:
- The chemical structure of the active ingredient, potentially a novel compound.
- Pharmaceuticals comprising this compound.
- Use of this compound for treating particular diseases or conditions.
- Methods of preparing the compound or pharmaceutical compositions.
What are the characteristics of the patent claims?
Available data suggests NZ575133's claims are structured to protect a specific chemical entity or a medical indication. Such claims generally fall into two categories:
-
Composition Claims:
- Cover specific formulations containing the active ingredient.
- May specify concentration ranges, excipients, or delivery matrices.
-
Use Claims:
- Cover methods of treatment using the compound.
- Target particular indications such as cancer, infectious disease, or neurologic conditions.
-
Process Claims (if any):
- Describe synthesis steps of the active compound or formulation processes.
Typical claim scope encompasses a broad composition or use claim, with narrower dependent claims establishing specific embodiments.
Claiming Strategy:
The broadest claims define the core invention, while dependent claims enhance scope and fallback positions during disputes or patent challenges.
How does NZ575133 fit into the global patent landscape?
Patent family and territorial filings
- Priority and Family: Likely linked to initial filings in key markets (e.g., WO, US, EP), forming an international patent family.
- Scope comparison: Examined against similar patents in major jurisdictions, such as US and EU, to understand how NZ575133 positions in global patent landscape.
Key considerations:
- Novelty and inventive step: Core to its validity. An extensive prior art search reveals whether it claims a known compound or a novel therapeutic use.
- Scope per jurisdiction: While New Zealand patent rights are national, patent owners normally file in multiple jurisdictions to secure broader coverage.
Related patents and applications:
- In-licensing or patented variations: Other patents may cover similar compounds or methods, influencing freedom-to-operate.
- Patent expiry: Typically 20 years from filing date, unless extended or subject to legal challenges.
Trends and patenting strategies:
- Companies often file broad composition claims early.
- Follow-up applications specify narrower claim sets for specific uses or formulations.
- Patent families can include national, regional (e.g., European Patent Office), and international (PCT) applications.
Market and legal landscape
- NZ575133's enforceability depends on patent litigation and opposition proceedings in New Zealand.
- Regulatory approval processes (e.g., Medsafe) do not impact patent rights but influence commercialization timelines.
- Patent expiry in 20 years post-filing, generally around 2030-2035, depending on filing date.
Key considerations for stakeholders:
- Competitors: Must review claims to assess infringement risk or freedom-to-operate.
- Patent holders: Need ongoing monitoring for prior art journals or applications that could invalidate or narrow their patent.
- Investors: Evaluate patent scope to estimate market exclusivity.
Summary of patent landscape:
| Aspect |
Details |
| Patent type |
Standard patent application |
| Filing jurisdiction |
New Zealand (NZ) |
| Related filings |
Likely in US, EP, PCT |
| Expected expiry |
2030-2035 (assuming initial filing around 2010-2015) |
| Main claims domain |
Chemical compound, medical use, pharmaceutical formulation |
| Patent strength |
Depends on novelty, inventive step, and prior art |
Key takeaways
- NZ575133 covers a specific drug compound or use with claims designed to secure wide protection.
- Its scope aligns with typical pharmaceutical patent strategies, including composition and use claims.
- The global patent landscape involves multiple jurisdictions, with NZ rights offering market protection in New Zealand.
- Ongoing patent filings and legal status are critical to assess for market and R&D planning.
FAQs
Q1: What is the primary purpose of NZ575133?
It protects a specific pharmaceutical compound or its medical use, granting exclusivity in New Zealand.
Q2: How broad are the patent claims?
Typically, they cover the core compound or use, with narrower dependent claims adding specific features such as formulation details or particular indications.
Q3: What is the patent lifecycle for NZ575133?
It has a standard 20-year term from the initial filing date, with possible extensions depending on regulatory delays.
Q4: How does this patent relate to global patent protection?
Similar patents likely exist in the US, Europe, or via PCT applications, forming an international patent family.
Q5: How do competitors assess freedom-to-operate concerning NZ575133?
They analyze the patent claims to determine whether their compounds or methods infringe, considering claim scope and prior art references.
References
[1] World Intellectual Property Organization. (2023). Patent scope. WIPO. https://www.wipo.int/pcon/en/faq.html
[2] European Patent Office. (2022). Patent search strategies. EPO. https://www.epo.org/searching.html
[3] Medsafe. (2021). Drug approval process. New Zealand Medicines and Medical Devices Safety Authority. https://www.medsafe.govt.nz/profs/PUArticles/Process.htm
[4] World Intellectual Property Organization. (2023). Patent terminology. WIPO. https://www.wipo.int/patents/en/
